World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
31169
World Ranking
13074
National Ranking
6676

Teresa L. Wright publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Teresa L. Wright sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 250 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Teresa L. Wright D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Teresa L. Wright sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Teresa L. Wright is affiliated with GlaxoSmithKline in the United States. Their research spans several fields, primarily focusing on biochemistry, genetics, molecular biology, social sciences, and medicine. The scientist's work covers a diverse range of topics relating to molecular biology and socio-political studies, reflecting interdisciplinary expertise.

Their recent publications include:

  • "Sustained Correction of a Murine Model of Phenylketonuria following a Single Intravenous Administration of AAVHSC15-PAH" (2020), Molecular Therapy - Methods & Clinical Development
  • "Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report" (2025), PEDIATRICS
  • "Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy Arsa Knock-Out Mice" (2023), Journal of Neuroscience
  • "Developments in China's Public Opinion from Hu to Xi: Corruption, Activism and Regime Legitimacy" (2023), The China Quarterly
  • "HMI-202: Investigational gene therapy for treatment of metachromatic leukodystrophy (MLD)" (2020), Molecular Genetics and Metabolism

Wright has collaborated frequently with several coauthors, including Nancy Avila, Albert Seymour, Omar L. Francone, Jason Lotterhand, and Jacinthe Gingras. These partnerships are reflected in multiple publications across their fields of study.

Key publication venues for their work include:

  • Molecular Genetics and Metabolism
  • The China Quarterly
  • Molecular Therapy - Methods & Clinical Development
  • PEDIATRICS
  • Journal of Neuroscience

Their scientific contributions extend into several main fields of study:

  • Biochemistry, Genetics and Molecular Biology
  • Social Sciences
  • Medicine

These fields are supported by a variety of subfields, such as:

  • Sociology and Political Science
  • Molecular Biology
  • Genetics
  • Physiology
  • Epidemiology

Themes and topics featured in Wright's work encompass:

  • Chinese history and philosophy
  • RNA modifications and cancer
  • Lysosomal Storage Disorders Research
  • Trypanosoma species research and implications
  • China's Socioeconomic Reforms and Governance
  • RNA regulation and disease
  • Metabolism and Genetic Disorders

In addition to articles, Wright has contributed to academic literature in book form. One notable publication is Accepting Authoritarianism, released by Stanford University Press eBooks in 2020, which has been cited in scholarly discourse.

Best Publications

  • Diagnosis, Management, and Treatment of Hepatitis C

    Doris B. Strader;Teresa Wright;Teresa Wright;David L. Thomas;Leonard B. Seeff;Leonard B. Seeff

  • Lamivudine as initial treatment for chronic hepatitis B in the United States.

    Jules L. Dienstag;Eugene R. Schiff;Teresa L. Wright;Robert P. Perrillo

  • Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.

    E. J. Heathcote;M. L. Shiffman;W. G. E. Cooksley;G. M. Dusheiko

  • HCV-related fibrosis progression following liver transplantation: increase in recent years

    Marina Berenguer;Linda Ferrell;Jessica Watson;Martin Prieto

  • Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test☆

    Thomas C. Wright;Mark H. Stoler;Catherine M. Behrens;Abha Sharma

  • Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

    Philip E Castle;Mark H Stoler;Thomas C Wright;Abha Sharma

  • Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

    Robert Perrillo;Eugene Schiff;Eric Yoshida;Ann Statler

  • Recurrent and acquired hepatitis C viral infection in liver transplant recipients.

    Teresa L. Wright;Teresa L. Wright;Teresa L. Wright;Elizabeth Donegan;Elizabeth Donegan;Elizabeth Donegan;Henry H. Hsu;Henry H. Hsu;Henry H. Hsu;Linda Ferrell;Linda Ferrell;Linda Ferrell

  • A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

    Robert P. Perrillo;Teresa Wright;Jorge Rakela;Gary Levy

  • A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An Update

    Emmet B. Keeffe;Douglas T. Dieterich;Steven–Huy B. Han;Ira M. Jacobson

  • Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C☆

    K. Rajender Reddy;Teresa L. Wright;Paul J. Pockros;Mitchell Shiffman

  • Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers

    X S He;B Rehermann;F X López-Labrador;J Boisvert

  • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.

    Emmet B. Keeffe;Douglas T. Dieterich;Steve Huy B. Han;Ira M. Jacobson

  • Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol

    Alexander Monto;Alexander Monto;Judy Alonzo;Judy Alonzo;Jessica J. Watson;Carl Grunfeld;Carl Grunfeld

  • Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

    Nezam H. Afdhal;Douglas T. Dieterich;Paul J. Pockros;Eugene R. Schiff

  • High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.

    Mark H. Stoler;Thomas C. Wright;Abha Sharma;Raymond Apple

  • "Occult" hepatitis B virus as source of infection in liver transplant recipients

    O. Chazouillères;D. Mamish;M. Kim;K. Carey

  • Hepatitis C and liver transplantation

    Marina Berenguer;F.Xavier López-Labrador;Teresa L. Wright

  • Multicenter study of lamivudine therapy for hepatitis B after liver transplantation

    Robert Perrillo;Jorge Rakela;Jules Dienstag;Gary Levy

  • A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C

    Hongjin Huang;Mitchell L. Shiffman;Scott Friedman;Ramasubbu Venkatesh

Frequent Co-Authors

Nancy L. Ascher
Nancy L. Ascher University of California, San Francisco
Linda D. Ferrell
Linda D. Ferrell University of California, San Francisco
John R. Lake
John R. Lake University of Minnesota
John P. Roberts
John P. Roberts University of California, San Francisco
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
Harry B. Greenberg
Harry B. Greenberg Stanford University
Robert G. Gish
Robert G. Gish University of Nevada Reno
Norah A. Terrault
Norah A. Terrault University of Southern California
Xiao-Song He
Xiao-Song He University of California, Davis
Emmet B. Keeffe
Emmet B. Keeffe Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in studying medicine in the USA but want to explore alternative or supporting healthcare roles, there are a range of flexible online options available. Many prospective students consider online MSN programs for non nurses, which offer an accelerated route to advanced nursing for those with a non-nursing bachelor’s degree.

For those looking for a quicker or less competitive entry into healthcare, you might research the easiest rn program to get into. These programs may have less stringent admission requirements, allowing students to start their nursing careers sooner.

Administrative and technical roles are another rewarding pathway. Those interested in the business side of healthcare can find reputable medical billing and coding schools online with financial aid, making it easier to enter this growing field with minimal upfront costs.

If traditional entrance exams are a concern, it’s worth considering a nursing school without teas test. These schools provide a pathway into nursing without the stress of standardized admissions testing.

Best Scientists Citing Teresa L. Wright

Trending Scientists

Recently Published Articles